Serum Sclerostin, Body Composition, and Sarcopenia in Hemodialysis Patients with Diabetes

المؤلفون المشاركون

Medeiros, Maria Carolina
Rocha, Natalia
Bandeira, Elba
Dantas, Isabel
Chaves, Conceição
Oliveira, Mario
Bandeira, Francisco

المصدر

International Journal of Nephrology

العدد

المجلد 2020، العدد 2020 (31 ديسمبر/كانون الأول 2020)، ص ص. 1-6، 6ص.

الناشر

Hindawi Publishing Corporation

تاريخ النشر

2020-02-10

دولة النشر

مصر

عدد الصفحات

6

التخصصات الرئيسية

الأمراض
الطب البشري

الملخص EN

Sclerostin (Scl) is an osteoblast-inhibiting glycoprotein that is secreted mainly by osteocytes and is regulated by hormonal changes and skeletal loading.

Decreased physical function and high serum Scl concentrations have been reported in chronic renal failure patients but little is known to date about the differences between diabetic and non-diabetic patients on hemodialysis who are susceptible to both sarcopenia and bone fragility.

Objective.To determine the prevalence of sarcopenia and its association with serum Scl concentrations and metabolic parameters in 92 patients on hemodialysis.

Anthropometric data and physical performance were evaluated in this study.

Blood samples were collected for Scl, glucose, cholesterol, triglycerides, calcium, phosphate, PTH, and 25 OH-vitamin D measurements.

Lean mass was evaluated using multifrequency electro-bioimpedance after dialysis session.

Results.

Mean age was 63.3 ± 13.6 years, 63% of patients were male, and 44.6% had diabetes.

Mean body mass index (BMI) was higher in diabetics (26.6 ± 5.2 vs.

24.1 ± 3.7; p=0.01) and there were no differences in gait speed and handgrip strength between diabetic and non-diabetic subjects.

A low skeletal muscle mass index (SMI) was identified in 65.2% of the participants, and among them 76.7% were men and 36.7% were diabetics.

Mean serum Scl was 86.9 ± 39.0 pmol/L, which was higher in men (94.6 ± 41.7; p=0.017), in those individuals with low SMI (94.9 ± 40.7; p<0.001), and in diabetics (97.2 ± 46.6; p<0.003).

After multivariate analysis and adjustments for potential confounders, high serum Scl was independently associated with low SMI and with the presence of diabetes.

The following variables correlated positively with diabetes: blood pressure; BMI; waist circumference; waist/hip ratio; plasma glucose; serum Scl; and fat mass.

Conclusions.

We found higher serum Scl concentrations in hemodialysis patients with diabetes and these were inversely related to muscle mass.

نمط استشهاد جمعية علماء النفس الأمريكية (APA)

Medeiros, Maria Carolina& Rocha, Natalia& Bandeira, Elba& Dantas, Isabel& Chaves, Conceição& Oliveira, Mario…[et al.]. 2020. Serum Sclerostin, Body Composition, and Sarcopenia in Hemodialysis Patients with Diabetes. International Journal of Nephrology،Vol. 2020, no. 2020, pp.1-6.
https://search.emarefa.net/detail/BIM-1172767

نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)

Medeiros, Maria Carolina…[et al.]. Serum Sclerostin, Body Composition, and Sarcopenia in Hemodialysis Patients with Diabetes. International Journal of Nephrology No. 2020 (2020), pp.1-6.
https://search.emarefa.net/detail/BIM-1172767

نمط استشهاد الجمعية الطبية الأمريكية (AMA)

Medeiros, Maria Carolina& Rocha, Natalia& Bandeira, Elba& Dantas, Isabel& Chaves, Conceição& Oliveira, Mario…[et al.]. Serum Sclerostin, Body Composition, and Sarcopenia in Hemodialysis Patients with Diabetes. International Journal of Nephrology. 2020. Vol. 2020, no. 2020, pp.1-6.
https://search.emarefa.net/detail/BIM-1172767

نوع البيانات

مقالات

لغة النص

الإنجليزية

الملاحظات

Includes bibliographical references

رقم السجل

BIM-1172767